"/> Invitrogen™ Peptide synthétique PCDH12 humain | B-LABO France

Invitrogen™ Peptide synthétique PCDH12 humain

Réf. : BL-RE-176676Réf. fabricant : 15339050 50 μg
141,00 € HT

Synthetic Peptide

Gene ID (Entrez)
51294
Espèces
Human
Méthode de purification
purified
Numéro d’adhésion
Q9NPG4
Nom usuel
Human PCDH12
Marque
Invitrogen

PCDH12 Synthetic Peptide, PEP-0818, from Invitrogen.

Protocadherins comprise the largest group within the cadherin family of calcium-dependent cell-cell adhesion molecules. Protocadherin 12 (PCDH12) was initially identified through PCR screening of mouse heart microvascular endothelial cell RNA; further experiments revealed its mRNA to be strongly expressed in highly vascularized organs such as lung and kidney, in addition to glycogen-rich trophoblasts in the placenta. PCDH12-null mice are viable and fertile, but show reduced placental and embryonic sizes when compared to wild-type mice. Further studies showed significant expression changes in 2, 289 genes, including those involved in tissue morphogenesis, angiogenesis, cell-matrix adhesion and migration, immune response and chromatin remodeling.

Caractéristiques techniques

MarqueInvitrogen
Réf. B-LABOBL-RE-176676
Réf. fabricant15339050
Gene ID (Entrez)51294
EspècesHuman
Méthode de purificationpurified
Numéro d’adhésionQ9NPG4
Nom usuelHuman PCDH12
Concentration200 μg/mL
Contenu et stockage-20°C
FormatLiquid
FormulePBS with 0.1% BSA and 0.02% sodium azide; pH 7.2
À utiliser avec (application)Blocking Assay, Control
Symbole de gène(s)PCDH12
LyophiliséNo
Conservateur0.02% sodium azide
Type de produitPeptide
Quantité50 μg
État réglementaireRUO - research use only
Tampon de stockagePBS
Une question, une configuration particulière ?
Contactez-nous pour un devis.